Trial
NCT00788606
R-CHOP-B Bevacizumab for Diffuse Large B Cell Lymphoma
Phase IITERMINATEDSAFETYConfidence: MEDIUM
Sponsor
Royal Marsden NHS Foundation Trust
Collaborators
Hoffmann-La Roche
Condition
Non-Hodgkin's Lymphoma
Intervention
bevacizumab, Rituximab
Why stopped
Toxicity and efficacy data from another trial
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2016-10-14